tirzepatide injection woodsboro Zepbound 15 mg/0.5 mL — Mountainside Medical FDA confirms tirzepatide shortage is
Description
In early October, the FDA pulled Eli Lillys tirzepatide sold as Mounjaro for diabetes and Zepbound for obesity off its drug shortage list after nearly two years

We are a leading provider of a range of trusted weight loss treatments

We utilize a precision medicine obesity model, combining these powerful pharmaceutical tools with bespoke Peptide Therapy , NAD+ support , and personalized nutrition plans to ensure that patients are losing fat, preserving muscle mass , and fundamentally improving their biological age, not just their physical appearance. This integrative approach, leveraging these powerful agents alongside complementary protocols, is the defining standard of doctor-supervised medical weight loss in Connecticut
Prioritize protein to preserve lean mass during weight loss
